PDT Partners LLC Invests $1.91 Million in Walgreens Boots Alliance, Inc. $WBA

Key Points

• PDT Partners LLC has purchased 170,622 shares of Walgreens Boots Alliance, Inc., valued at approximately $1,906,000, marking a significant new stake in the company.
• Institutional ownership stands at 58.59%, with several hedge funds recently adjusting their positions, indicating ongoing interest from institutional investors.
• Walgreens Boots Alliance reported $0.38 EPS for the last quarter, surpassing estimates and showing a revenue growth of 7.2% year-over-year, with a consensus rating of "Reduce" from analysts.

PDT Partners LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 170,622 shares of the pharmacy operator's stock, valued at approximately $1,906,000.

A number of other hedge funds have also recently added to or reduced their stakes in WBA. TIG Advisors LLC raised its position in shares of Walgreens Boots Alliance by 2,729.3% in the first quarter. TIG Advisors LLC now owns 2,181,026 shares of the pharmacy operator's stock valued at $24,362,000 after buying an additional 2,103,940 shares during the last quarter. Focus Partners Advisor Solutions LLC bought a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $236,000. Alpine Global Management LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $1,117,000. MAI Capital Management grew its stake in shares of Walgreens Boots Alliance by 1.9% during the first quarter. MAI Capital Management now owns 57,827 shares of the pharmacy operator's stock valued at $646,000 after purchasing an additional 1,055 shares during the last quarter. Finally, Quarry LP grew its stake in Walgreens Boots Alliance by 382.4% in the first quarter. Quarry LP now owns 6,735 shares of the pharmacy operator's stock valued at $75,000 after acquiring an additional 5,339 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

NASDAQ WBA remained flat at $11.98 during mid-day trading on Monday. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The company's fifty day simple moving average is $11.75 and its two-hundred day simple moving average is $11.32. The stock has a market capitalization of $10.37 billion, a price-to-earnings ratio of -1.64, a price-to-earnings-growth ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company had revenue of $38.99 billion during the quarter, compared to analysts' expectations of $36.72 billion. During the same period last year, the company posted $0.63 earnings per share. The business's revenue for the quarter was up 7.2% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, six have given a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus price target of $10.15.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.